Pharmafile Therapeutic areas in focus Volume 69 Spring 2020 EXCLUSIVE INTERVIEW Novartis’ Rod Wooten examines what COVID-19 means for the global threat of cardiovascular disease In affiliation with Pharmafocus Allogeneic cell- A roadmap to successful...
More
Pharmafile Therapeutic areas in focus Volume 69 Spring 2020 EXCLUSIVE INTERVIEW Novartis’ Rod Wooten examines what COVID-19 means for the global threat of cardiovascular disease In affiliation with Pharmafocus Allogeneic cell- A roadmap to successful derived therapies treatment of Alzheimer’s How alternative cell therapy approaches How tau proteins could offer new insight can overcome oncology’s challenges into the disease
Less
